期刊文献+

胰岛素对前列腺癌LNCaP细胞的抑制作用 被引量:1

Inhibitory effect of insulin on prostate cancer LNCaP cell line
原文传递
导出
摘要 目的观察胰岛素对前列腺癌LNCaP细胞系增殖、活力、迁移与侵袭能力的影响,并探讨其机制。方法胰岛素刺激LNCaP细胞后,采用实时荧光定量聚合酶链反应(Real-time PCR)、蛋白免疫印迹(Western blotting)、免疫细胞化学(ICC)法检测胰岛素受体表达变化;细胞计数法、四唑盐法(MTT)、细胞划痕、细胞侵袭实验(Transwell)检测细胞增殖、活力、迁移和侵袭能力;Western blotting检测Ras、ERK1/2、MEK1/2蛋白水平表达变化。结果胰岛素可促进LNCaP细胞胰岛素受体的表达,抑制其增殖、活力、迁移及侵袭能力,同时抑制其Ras的表达及ERK1/2、MEK1/2的磷酸化(P<0.05)。结论胰岛素可通过胰岛素受体抑制Ras-MEK-ERK信号通路的活化,从而抑制LNCaP细胞的增殖、活力、迁移及侵袭。 Objective To study the inhibitory effect of insulin on LNCaP human prostate cancer cell line and its possible mechanism. Methods After LNCaP cells were treated with insulin,the expression of insulin receptor was detected with Real-time PCR,immunocytochemistry and Western blotting. The effects of insulin on cell growth,viability,migration and invasion were measured by cell counting,MTT,wound healing and Transwell. The activation of MAPK pathway was determined by Western blotting. Results Insulin increased the mRNA and protein expressions of INSR in LNCaP cells,and inhibited the cell growth,viability,migration and invasion. Expressions of key proteins in the MAPK pathway,including Ras,p-MEK and p-ERK,were significantly lowered by insulin. Conclusion Insulin can inhibit prostate cancer LNCaP cell line through MAPK signal pathway.
出处 《山东大学学报(医学版)》 CAS 北大核心 2014年第7期22-27,共6页 Journal of Shandong University:Health Sciences
基金 山东省科学技术发展项目(26010104011178)
关键词 前列腺肿瘤 胰岛素 胰岛素受体 MAPK信号通路 Prostatic neoplasms Insulin Insulin receptor MAPK pathway
  • 相关文献

参考文献18

  • 1Jemal A, Bray F, Center M M, et al. Global cancer sta- tistics CA cancer[J]. CA Cancer J Clin, 2011, 61 (2) : 69 -90.
  • 2唐志柳,白洁,顾丽娜,李岚,薛迪.2000~2010年我国前列腺癌和乳腺癌流行状况的系统性综述[J].中国肿瘤,2013,22(4):260-265. 被引量:116
  • 3Saman D M, Lemieux A M, Nawal Lutfiyya M, et al. A review of the current epidemiology and treatment options for prostate cancer[J]. Dis Mon, 2014, 60(4) : 150-154.
  • 4Lawrenson R, Obertov6 Z, Brown C, et al. The use of androgen deprivation therapy and chemotherapeutic agents in New Zealand men with prostate cancer[ J]. J Cancer, 2014, 5 (3) :214-220.
  • 5Kasper J S, Giovannucci E. A meta-analysis of diabetes mellitus and the risk of prostate cancer[J]. Cancer Epide- miol Biomarkers Prev, 2006, 15( 11 ) : 2056-2062.
  • 6Rodriguez C, Patel A V, Mondul A M, et al. Diabetes and risk of prostate cancer in a prospective cohort of US men[J]. Am J Epidemiol, 2005, 161(2) : 147-152.
  • 7Stagi S, Lapi E, Pantaleo M, et al. Type II diabetes and impaired glucose tolerance due to severe hyperinsulinism in patients with lp36 deletion syndrome and a Prader-Wil- li-like phenotype [ J ]. BMC Med Genet, 2014, 15 : 16. doi: 10.1186/1471-2350-15-16.
  • 8Leitzmann M F, Ahn J, Albanes D, et al. Diabetes mel- litus and prostate cancer risk in the Prostate, Lung, Color- ectal, and Ovarian Cancer Screening Trial [ J ]. Cancer Causes Control, 2008, 19(10) :1267-1276.
  • 9Zelenko Z, Gallagher E J. Diabetes and Cancer [J]. En- docrinol Metab Clin North Am, 2014, 43( 1 ) :167-185.
  • 10Starup-Linde J, Karlstad O, Eriksen S A, et al. CAR- ING: the association of diabetes mellitus and cancer risk with focus on possible determinants--a systematic review and a meta-analysis[J]. Curr Drug Saf, 2013, 8(5) : 296-332.

二级参考文献42

  • 1叶延程,罗好曾.武威市女性乳腺癌发病现况研究[J].中华肿瘤防治杂志,2001,12(z1):180-181. 被引量:3
  • 2王启俊,祝伟星,邢秀梅.北京城区女性乳腺癌发病死亡和生存情况20年监测分析[J].中华肿瘤杂志,2006,28(3):208-210. 被引量:81
  • 3刘丽,丁辉,王连英,邱立苹,陶旻枫,潘迎.北京地区2000~2005年妇女病普查结果分析[J].中国全科医学,2006,9(15):1275-1276. 被引量:38
  • 4Yang W,Lu J,Weng J,et al.Prevalence of diabetes among men and women in China[J].N Engl J Med,2010,362(12):1090-1101.
  • 5Larsson SC,Orsini N,Wolk A.Diabetes mellitus and risk of colorectal cancer:a meta-analysis[J].J Natl Cancer Inst,2005,97(22):1679-1687.
  • 6Huxley R,Ansary-Moghaddam A,Berrington de Gonzalez A,et al.Type-Ⅱ diabetes and pancreatic cancer:a meta-analysis of 36 studies[J].Br J Cancer,2005,92(11):2076-2083.
  • 7Liao S,Li J,Wei W,et al.Association between diabetes mellitus and breast cancer risk:a Meta-analysis of the literature[J].Asian Pac J Cancer Prev,2011,12(4):1061-1065.
  • 8Sciacca L,Prisco M,Wu A,et al.Signaling differences from the A and B isoforms of the insulin receptor(IR)in 32D cells in the presence or absence of IR substrate-1[J].Endocrinology,2003,144(6):2 2650-2658.
  • 9Slaaby R,Sch(a)ffer L,Lautrup-Larsen I,et al.Hybrid receptors formed by insulin receptor(IR)and insulin-like growth factor Ⅰ receptor(IGF-IR)have low insulin and high IGF-1 affinity irrespective of the IR splice variant[J].J Biol Chem,2006,281(36):25869-25874.
  • 10Frasca F,Pandini G,Scalia P,et al.Insulin receptor isoform A,a newly recognized,high-affinity insulin-like growth factorⅡreceptor in fetal and cancer cells[J].Mol Cell Biol,1999,19(5):3278-3288.

共引文献124

同被引文献20

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部